Table 1.

Clinicopathological data for the 15 patients with follicular thyroid carcinomas analyzed

Patient	Sex	Age, y	Tumor size, cm	Metastases	Disease stage	Follow- up time, mo	Patient status
1	M	36	6.0	None	I	65	ANED
2	F	45	6.5	None	III	105	ANED
3	M	57	2.0	None	I	93	ANED
4a	F	69	2.5	None	II	120	DNED
5	F	79	2.0	None	I	84	ANED
6d	M	23	3.2	None	I	161	ANED
7d	M	68	4.0	None	II	94	ANED
8d	F	69	4.0	None	II	158	ANED
9	M	77	5.5	Boneb	IVc	89	ANED
10	M	47	11.0	Bone, lung, CNS	IVa	26	DWD
11	M	49	15.0	Lymph nodesb	IVa	212	DWD
12c	F	65	6.0	Bone, lungb	IVc	33	DWD
13	M	66	16.0	Bone, lung, liver gingivab	IVc	9	DWD
14	M	78	2.6	Bone, kidneyb	IVc	71	DWD
15c	M	73	8.5	Bone, lung	III	36	DWD

Abbreviations: ANED–alive, no evidence of disease; CNS–central nervous system; DNED–dead, no evidence of disease; DWD–dead with disease; mo–months; y–years.

^aPPARg expression elevated consistent with the PAX8/PPARg translocation (t(2;3)(q13;25).

^bMetastases were present at initial diagnosis.

^cPoorly differentiated features present.

^dHurthle cell phenotype.